Showing results (41-50 of 102) with videos related to

Sort By:
Pageof 11
Antiviral Therapy|February 19, 2016
High serum HCV RNA in chronic hepatitis C patients coinfected with HIV despite successful antiretroviral therapyPablo Barreiro, Pablo Labarga, Carmen de Mendoza, et al.
Expert Opinion on Pharmacotherapy|April 30, 2013
Hepatitis C therapy with HCV NS5B polymerase inhibitorsVincent Soriano, Eugenia Vispo, Carmen de Mendoza, et al.
The Journal of Infectious Diseases|March 3, 2007
Influence of liver fibrosis stage on plasma levels of antiretroviral drugs in HIV-infected patients with chronic hepatitis CPablo Barreiro, Sonia Rodríguez-Novoa, Pablo Labarga, et al.
AIDS (London, England)|February 16, 2010
Survival of HIV-infected patients with compensated liver cirrhosisPaula Tuma, Inmaculada Jarrin, Julia Del Amo, et al.
Antiviral Therapy|February 2, 2012
Predicted effect of direct acting antivirals in the current HIV-HCV-coinfected population in SpainEva Poveda, Eugenia Vispo, Pablo Barreiro, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 3, 2006
Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3Pablo Barreiro, Luz Martín-Carbonero, Marina Núñez, et al.
AIDS (London, England)|February 20, 2010
Safety and efficacy of tenofovir/emtricitabine plus nevirapine in HIV-infected patientsPablo Labarga, Jose Medrano, Eduardo Seclen, et al.
Current HIV/AIDS Reports|July 10, 2015
Emerging challenges in managing hepatitis B in HIV patientsVincent Soriano, Pablo Labarga, Carmen de Mendoza, et al.
Infectious Disorders Drug Targets|June 22, 2006
Chronic hepatitis C in HIV-infected patients: those who more need therapy are those who respond lessVincent Soriano, Marina Nuñez, Javier Garcia-Samaniego, et al.
Pageof 11